Sebelipase Alfa
ATC A16AB14 · 6 markets · 7 records
AU 2 records · 2 strengths
- 2 mg/mLinjectionKANUMA sebelipase alfa rce 2 mg/mL injection intravenous infusion vial
Records without a stated strength · 1 KANUMA
GB 1 records · 1 strengths
- 20 mg/10 mLinjectionKanuma 20mg/10ml concentrate for solution for infusion vials
CA 1 records · 1 strengths
- 2 mgliquidKANUMA
SG 1 records · 1 strengths
- 2 mg/mLinjectionKANUMA CONCENTRATE FOR SOLUTION FOR INFUSION 2 MG/ML
HK 1 records · 1 strengths
Records without a stated strength · 1 KANUMA CONCENTRATE FOR SOLUTION FOR INFUSION 20MG/10ML
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 KANUMA
| Strength / form / release | GB | CA | AU | SG | HK | EU |
|---|---|---|---|---|---|---|
| 2 mg/mL injection | KANUMA sebelipase alfa rce 2 mg/mL injection intravenous infusion vial | KANUMA CONCENTRATE FOR SOLUTION FOR INFUSION 2 MG/ML | ||||
| 2 mg liquid | KANUMA | |||||
| 20 mg/10 mL injection | Kanuma 20mg/10ml concentrate for solution for infusion vials | |||||
unknown | KANUMA | KANUMA CONCENTRATE FOR SOLUTION FOR INFUSION 20MG/10ML | KANUMA |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.